Mesotheliomas are tumors arising from mesothelial cells and are associated with asbestos exposure and approximately 50% contain simian virus 40 (SV40) DNA sequences. SV40 infection of human mesothelial cells (HM) causes early cellular immortalization and late transformation. Aberrant methylation is a major mechanism for loss of function of tumor suppressor genes (TSGs). We recently reported that of seven genes frequently methylated in epithelial tumors, only RASS-F1A gene was frequently methylated in mesotheliomas, and its methylation was correlated with loss of RASSF1A expression and the presence of SV40. We studied whether SV40 infection of normal HM induces aberrant methylation of the genes previously studied in mesotheliomas. Of six infected foci examined at early passages (passages 8 ± 30) there was no methylation of the seven genes examined. Of two foci examined at late passages (passages 51 ± 86) after the appearance of morphological changes suggestive of transformation, methylation and loss of expression of RASSF1A was detected. Sequencing of the CpG dense region around the transcription start site and semi-quantitative real-time methylation speci®c PCR (MSP) assay for RASSF1A methylation demonstrated progressive methylation during late passages. Exposure to the demethylating agent 5-aza-2'-deoxycytidine restored RASSF1A expression, while exposure to the histone deacetylation inhibitor trichostatin A had no eect. These data, together with our previous ®ndings, support a causal relationship between SV40 infection, progressive RASSF1A methylation and its silencing, and the pathogenesis of mesothelioma.
Mesotheliomas are tumors arising from mesothelial cells and are associated with asbestos exposure and approximately 50% contain simian virus 40 (SV40) DNA sequences. SV40 infection of human mesothelial cells (HM) causes early cellular immortalization and late transformation. Aberrant methylation is a major mechanism for loss of function of tumor suppressor genes (TSGs). We recently reported that of seven genes frequently methylated in epithelial tumors, only RASS-F1A gene was frequently methylated in mesotheliomas, and its methylation was correlated with loss of RASSF1A expression and the presence of SV40. We studied whether SV40 infection of normal HM induces aberrant methylation of the genes previously studied in mesotheliomas. Of six infected foci examined at early passages (passages 8 ± 30) there was no methylation of the seven genes examined. Of two foci examined at late passages (passages 51 ± 86) after the appearance of morphological changes suggestive of transformation, methylation and loss of expression of RASSF1A was detected. Sequencing of the CpG dense region around the transcription start site and semi-quantitative real-time methylation speci®c PCR (MSP) assay for RASSF1A methylation demonstrated progressive methylation during late passages. Exposure to the demethylating agent 5-aza-2'-deoxycytidine restored RASSF1A expression, while exposure to the histone deacetylation inhibitor trichostatin A had no eect. These data, together with our previous ®ndings, support a causal relationship between SV40 infection, progressive RASSF1A methylation and its silencing, and the pathogenesis of mesothelioma. Oncogene (2002) 21, 4340 ± 4344. doi:10.1038/sj.onc. 1205381
Keywords: SV40; methylation; RASSF1A; mesothelial cell; mesothelioma Malignant mesothelioma (MM), a tumor of the lining cells of mesothelial surfaces of the pleura, pericardium and peritoneum is resistant to current therapeutic approaches (Antman et al., 2001; Testa et al., 2001) . Asbestos exposure shows a strong epidemiological association with human MMs, and MM has been recently linked to simian virus 40 (SV40) and to genetic predisposition . About 50% of MMs contain SV40 large T antigen DNA sequences and protein. SV40 is present in the MM cells but not in the surrounding stroma (Carbone et al., 1994) or in the adjacent lung tissue (Shivapurkar et al., 1999) . The mechanisms of SV40 pathogenesis in mesothelioma are being investigated (Klein et al., 2002) .
Aberrant promoter methylation is a major mechanism for silencing TSGs in many kinds of malignant tumors (Baylin et al., , 2001 Herman, 1999; Merlo et al., 1995) . RASSF1A gene is a recently described TSG located at 3p21, and its expression is silenced by aberrant methylation in several kinds of cancers including lung, breast, kidney, gastric, ovary and bladder Burbee et al., 2001; Dammann et al., 2000; Morrissey et al., 2001; Toyooka et al., 2001) . While there is relatively little information about the methylation patterns of MMs, we recently studied the methylation status of seven genes in MM . Of these genes, only RASSF1A methylation (32%) was present at a frequency above 12% . Furthermore, aberrant methylation of RASSF1A was preferentially related to the presence of SV40 DNA sequences (P=0.02) .
Human mesothelial cells (HM) are unusually susceptible to transformation by SV40 (Bocchetta et al., 2000; Cacciotti et al., 2001 ), a process that may be facilitated by exposure to asbestos, suggesting that SV40 and asbestos might act as co-carcinogens (Bocchetta et al., 2000; Klein, 2000) . While SV40 infection results in the activation of the immortality associated enzyme, telomerase (Foddis et al., 2002) , transformation of HM is not rapid and takes six or more weeks to appear. We studied the methylation patterns of foci of HM infected with SV40 during serial passage.
As previously reported ) and recon®rmed in this study, in primary uninfected HM cultures expression of RASSF1A mRNA was present, SV40 sequences were absent and only the unmethylated forms of the seven genes tested were detected. Early passages (less than 30 passage) of six foci of SV40 infected cells (in the absence of asbestos exposure) were tested. Later passage cells (passages 51 ± 86) of two of these foci were also available for testing and had the distinctive morphological features of transformed HM (small and spindle shaped morphology). The presence of SV40 sequences was demonstrated by PCR and by SV40-large T antigen immunostaining in all SV40 Mean number of methylated CpG sites (of the 10 clones analysed for each passage) expressed as a percentage of total number of sites (n=58) of RASSF1A 5'¯anking region as determined by sequencing ( Figure 2B ). b Real-time MSP assay was performed for semi-quantitative measurement of RASSF1A aberrant methylation, based on uorescent TaqMan methodolgy (see legend of Figure 2 ). Semi-quantitative ratio was calculated by the following forumula: Quantitative ratio=[RASSF1A methylated DNA amount]/[MYOD1 DNA amount] multiplied by 1000. Expression of RASSF1A mRNA was examined by RT ± PCR. +=PCR product positive; 7=PCR product negative; ND=not done Figure 1 Methylation-speci®c polymerase chain reaction (MSP) assay and SV40 DNA sequence ampli®cation. Data from six SV40 infected human mesothelial cells (HM) foci (F) at dierent passages (p) are illustrated. Results of testing for the methylation and unmethylated forms of RASSF1A gene and for the presence of SV40 DNA sequences are illustrated. P=positive control and N=negative control (water blank). SV40 infected HM were established and passaged by author M Carbone as previously described (Bocchetta et al., 2000) . Four non-malignant mesothelial primary cell cultures were established from pleural eusions that arose in patients free of cancer and which demonstrated normal or reactive cytological changes. Genomic DNA was isolated from 11 samples (F1p12, F1p51, F1p70, F1p86, F2p20, F3p8, F3p30, F4p11, F4p60, F6p20 and F14p12) . PCR were performed for all HM DNAs to speci®cally amplify the 105 bp of the retinoblastoma protein binding domain of the large T antigen region of SV40 (Shivapurkar et al., 1999) and not that of any other virus . Aberrant methylation of the RASSF1A, GSTP1, p16, RARb, APC, CDH13 and MGMT genes was determined using gene-speci®c primers by the method of MSP (Burbee et al., 2001; Esteller et al., 1998 Esteller et al., , 2000 Herman et al., 1996; Toyooka et al., 2001; Virmani et al., 2000 Virmani et al., , 2001 as described previously (only RASSF1A shown). DNA from peripheral blood lymphocytes and buccal mucosa scrapings of 10 healthy subjects and water blanks were used as negative controls for the methylated genes. DNA from lymphocytes of a healthy volunteer treated with Sss1 methyltransferase (New England BioLabs, Beverly, MA, USA) and then subjected to bisul®te treatment was used as a positive control for methylated alleles. PCR products were visualized on 2% agarose gels stained with ethidium bromide The numbers on the top indicate the CpG sites in the amplicon (5' to 3'). PCR products of bisul®ted genomic DNA of F1p12, F1p51, F1p70, F1p86, F4p11 and F4p60 were cloned into plasmid vectors using the Topo TA cloning kit (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. Plasmid DNAs were puri®ed using the Wizard Plus miniprep kit (Promega, Madison, WI, USA), and then sequenced by Applied Biosystems PRISM dye terminator cycle sequencing method (Perkin-Elmer Corp., Foster City, CA, USA). RASSF1A MS and MR primers were designed to bind to three (forward primer) or four (reverse primer) CpG sites (sites 2 to 4 and 15 to 18 respectively). RAK3 and RAK2 primers and RAK probe for semi-quantitative real-time MSP assay were designed to bind to four CpG sites each (from sites 13 to 16 and 32 to 35 and 18 to 21 respectively) and presence of unmethylated CpG sites results in reduced or absent PCR eciency. Primers and probe sequences are as follows: RAK3: GTGGTTTCGTTCGGTTCGC, RAK Probe: 6FAM5'-CCGACATAACCCGATTAAACCCGTACTTCG-3' TAMRA, RAK2: CGATACCCC-GCGCGA. Semi-quantitative real-time MSP assay was performed by the method of Eads (2000) . The RASSF1A signal was normalized to the signal for MYOD1, which was utilized as an internal control (Table 1 ). The MYOD1 control reaction was designed to be independent of CpG sites and thus re¯ects the amount and integrity of input genomic DNA RASSF1A in SV40 infected mesothelial cells S Toyooka et al infected HM at all passages tested, con®rming successful infection and retention of viral sequences in 100% of the cells in each focus. Aberrant methylation of the RASSF1A, GSTP1, p16, RARb, APC, CDH13 and MGMT genes was determined using gene-speci®c primers by the method of methylation speci®c PCR (MSP) assay. MSP assays indicated lack of methylated forms of six of the seven genes tested in all passages of the six foci (data not shown). Aberrant RASSF1A promoter methylation was absent in early passages of all six foci (Table 1, Figure 1) . However, in all of the later passages of the two foci tested (foci F1 and F4 at passages 51 to 86) aberrant methylation of RASSF1A gene was present. However, an unmethylated or partially methylated band was present in all passages of all of the foci (Table 1, Figure 1) .
Because of the presence of the unmethylated band, we performed sequencing of cloned bisul®te treated genomic DNA obtained from multiple passages of foci F1 and F4 (Figure 2b ). The sequenced amplicon included 58 CpG sites covering the region from 177 bp upstream to 349 bp downstream of the transcription start site (Figure 2a ). This region satis®ed the criteria for a CpG island (Gardiner-Garden and Frommer, 1987) . Ten clones of the PCR amplicon from each passage were sequenced. As demonstrated in Table 1 and Figure  2b , there was minimal methylation in early passage and progressively increasing methylation during later passages. While all clones of late passages demonstrated considerable methylation at CpG sites, a modest degree of clonal heterogeneity was present (Figure 2b ). Semiquantitative real-time MSP assay was performed on serial passages of all foci (Table 1) . These results mirrored those of bisul®ted genomic sequencing.
Expression RASSF1 transcripts were examined by RT ± PCR in serial passages of foci F1, F3 and F4 (Table 1, Figure 3 ). Three transcripts are derived from two promoters which are dierentially methylated in tumors (Burbee et al., 2001 ). Promoter 1B is not known to be methylated in tumors, and its transcript RASSF1C was expressed in all passages tested of the three foci. In contrast, there was no expression of transcripts RASSF1A and RASSF1F in late passages, despite the presence of unmethylated or partially methylated alleles. These transcripts are controlled by promoter 1A, which is methylated in several tumor types. We presume that heterogeneity of methylation permitted attachment of the unmethylated primers to some alleles. However, the extensive methylation in all alleles prevented expression of the 1A and 1F transcripts. Treatment 5-aza-2'-deoxycytidine (5-AzaCdR) restored expression of RASSF1A and F transcripts in late passages of foci 1 and 4 ( Figure 3) and was accompanied by an increase in cell size and morphological change similar to those of uninfected epitheloid mesothelial cells. However, expression was not restored by exposure to the histone deacetylase inhibitor trichostatin A (TSA) even though CpG sites of promoter region were not completely methylated. These data suggest that methylation rather than histone deacetylation is the major mechanism of RASSF1A silencing in SV40 transformation of HM.
Recent studies have strengthened the association of SV40 and MM Klein et al., 2002) . HM are highly susceptible to SV40 transformation (Bocchetta et al., 2000; Cacciotti et al., 2001 ), a mechanism related to p53 (Bocchetta et al., 2000) . SV40 infection of HM inactivates p53 and retinoblastoma protein De Luca et al., 1997) and induces hepatocyte growth factor/Met receptor activity which promotes mesothelial cell growth (Cacciotti et al., 2001) . SV40 infection of HM results in immediate activation of telomerase (Foddis et al., 2002) , which precedes the transformed phenotype. Accordingly, antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigenpositive MMs (Waheed et al., 1999) .
Our previous work ) has revealed a relationship between the presence of SV40 sequences in MM and methylation of the RASSF1A promoter and silencing of its transcripts (P=0.02). Figure 3 Representative example of RASSF1 transcripts expression before and after treatment with 5-Aza-CdR and TSA. RASSF1 transcripts A, C and F (GenBank Accession nos. AF102770, AF040703, and AF286217, respectively) were analysed by RT ± PCR as described by us previously (Burbee et al., 2001) . Total RNA was extracted from the HM foci at dierent passages as listed in Table 1 . Late passage foci (F1p51, F1p70, F1p86 and F4p60) with RASSF1A methylation and absent RASSF1A expression were incubated in culture medium with 5-aza-2'-deoxycytidine (5-Aza-CdR) and trichostatin A (TSA) separately. Drug treatment was accomplished by adding reagents to the culture medium to ®nal concentrations as follows: (a) 5-Aza-CdR, 5 mM; and (b) TSA, 150 and 300 nM. Cells were treated with 5-Aza-CdR for 5 days and TSA for 48 h. Media were changed every 48 h for 5-Aza-CdR and 24 h for TSA. P=positive control and N=negative control (water blank) Thus, selective silencing of RASSF1A may be an important mechanism in the pathogenesis of SV40 associated mesotheliomas. The results of this study indicate that selective and progressive methylation of the 1A promoter of the RASSF1A gene after SV40 infection results in silencing of its speci®c transcripts in HM. We have demonstrated that SV40 sequences appear early during the pathogenesis of MM, and can be demonstrated in non-invasive components and in non-malignant reactive mesothelium (Shivapurkar et al., 1999) . Our present ®ndings suggest that methylation and silencing of RASSF1A may be a useful approach for early detection of MM, perhaps at a preclinical stage. In aggregate, our ®ndings that the RASSF1A gene becomes progressively methylated and thus inactive in SV40 infected HM, and that RASSF1A is methylated preferentially in this model of human mesotheliomas, support the role of SV40 in the pathogenesis of MM. 
